Headlands Technologies LLC Buys 51,905 Shares of Sabra Healthcare REIT, Inc. $SBRA

Headlands Technologies LLC lifted its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 333.1% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 67,486 shares of the real estate investment trust’s stock after acquiring an additional 51,905 shares during the period. Headlands Technologies LLC’s holdings in Sabra Healthcare REIT were worth $1,317,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Rothschild Investment LLC grew its holdings in Sabra Healthcare REIT by 164.6% in the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 889 shares during the period. Smartleaf Asset Management LLC increased its stake in Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares in the last quarter. Strengthening Families & Communities LLC acquired a new position in shares of Sabra Healthcare REIT during the fourth quarter valued at about $29,000. Versant Capital Management Inc raised its holdings in shares of Sabra Healthcare REIT by 70.0% during the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 603 shares during the period. Finally, Danske Bank A S acquired a new position in shares of Sabra Healthcare REIT during the third quarter valued at about $30,000. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Stock Performance

SBRA opened at $20.39 on Tuesday. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.95. The company’s fifty day moving average price is $20.47 and its two-hundred day moving average price is $20.17. Sabra Healthcare REIT, Inc. has a 1-year low of $17.17 and a 1-year high of $22.77. The company has a market cap of $5.21 billion, a price-to-earnings ratio of 78.43, a PEG ratio of 1.57 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). The business had revenue of $230.11 million for the quarter, compared to analyst estimates of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The firm’s quarterly revenue was up 24.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.38 earnings per share. On average, analysts expect that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 annualized dividend and a yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 461.54%.

Analysts Set New Price Targets

SBRA has been the subject of several research reports. Scotiabank reduced their target price on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Barclays upped their price target on Sabra Healthcare REIT from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Monday. Weiss Ratings lowered Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, August 4th. Wells Fargo & Company raised their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Finally, Cantor Fitzgerald raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, Sabra Healthcare REIT currently has a consensus rating of “Hold” and an average price target of $22.17.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.